1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN. 2Multidisciplinary Epidemiology and Translational Research in Intensive Care, Mayo Clinic, Rochester, MN. 3Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN. 4Division of Trauma, Critical Care and General Surgery, Mayo Clinic, Rochester, MN.
Crit Care Med. 2014 Jan;42(1):31-9. doi: 10.1097/CCM.0b013e318298a6db.
Acute respiratory distress syndrome is a common complication of critical illness, with high mortality and limited treatment options. Preliminary studies suggest that potentially preventable hospital exposures contribute to acute respiratory distress syndrome development. We aimed to determine the association between specific hospital exposures and the rate of acute respiratory distress syndrome development among at-risk patients.
Population-based, nested, Matched case-control study.
Consecutive adults who developed acute respiratory distress syndrome from January 2001 through December 2010 during their hospital stay (cases) were matched to similar-risk patients without acute respiratory distress syndrome (controls). They were matched for 6 baseline characteristics.
None.
Trained investigators blinded to outcome of interest reviewed medical records for evidence of specific exposures, including medical and surgical adverse events, inadequate empirical antimicrobial treatment, hospital-acquired aspiration, injurious mechanical ventilation, transfusion, and fluid and medication administration. Conditional logistic regression was used to calculate the risk associated with individual exposures. During the 10-year period, 414 patients with hospital-acquired acute respiratory distress syndrome were identified and matched to 414 at-risk, acute respiratory distress syndrome-free controls. Adverse events were highly associated with acute respiratory distress syndrome development (odds ratio, 6.2; 95% CI, 4.0-9.7), as were inadequate antimicrobial therapy, mechanical ventilation with injurious tidal volumes, hospital-acquired aspiration, and volume of blood products transfused and fluids administered. Exposure to antiplatelet agents during the at-risk period was associated with a decreased risk of acute respiratory distress syndrome. Rate of adverse hospital exposures and prevalence of acute respiratory distress syndrome decreased during the study period.
Prevention of adverse hospital exposures in at-risk patients may limit the development of acute respiratory distress syndrome.
急性呼吸窘迫综合征是危重病的常见并发症,死亡率高,治疗选择有限。初步研究表明,潜在可预防的医院暴露会导致急性呼吸窘迫综合征的发生。我们旨在确定特定医院暴露与高危患者急性呼吸窘迫综合征发展率之间的关系。
基于人群的嵌套病例对照研究。
2001 年 1 月至 2010 年 12 月期间在住院期间发生急性呼吸窘迫综合征的连续成年患者(病例)与无急性呼吸窘迫综合征的类似风险患者(对照)相匹配。他们匹配了 6 项基线特征。
无。
受过培训的调查员对感兴趣的结果进行了盲法审查,以评估特定暴露的证据,包括医疗和手术不良事件、经验性抗菌治疗不足、医院获得性吸入、有创机械通气、输血以及液体和药物管理。使用条件逻辑回归计算与个体暴露相关的风险。在 10 年期间,确定了 414 例医院获得性急性呼吸窘迫综合征患者,并与 414 例高危、无急性呼吸窘迫综合征的对照患者相匹配。不良事件与急性呼吸窘迫综合征的发生高度相关(比值比,6.2;95%置信区间,4.0-9.7),经验性抗菌治疗不足、具有创性潮气量的机械通气、医院获得性吸入以及输血量和液体给予量也与急性呼吸窘迫综合征的发生相关。高危期间接触抗血小板药物与急性呼吸窘迫综合征的风险降低相关。在研究期间,不良医院暴露的发生率和急性呼吸窘迫综合征的患病率均下降。
在高危患者中预防不良医院暴露可能会限制急性呼吸窘迫综合征的发生。